DNA repair targeted therapy: The past or future of cancer treatment?

Pharmacology & Therapeutics
Navnath S GavandeJohn J Turchi

Abstract

The repair of DNA damage is a complex process that relies on particular pathways to remedy specific types of damage to DNA. The range of insults to DNA includes small, modest changes in structure including mismatched bases and simple methylation events to oxidized bases, intra- and interstrand DNA crosslinks, DNA double strand breaks and protein-DNA adducts. Pathways required for the repair of these lesions include mismatch repair, base excision repair, nucleotide excision repair, and the homology directed repair/Fanconi anemia pathway. Each of these pathways contributes to genetic stability, and mutations in genes encoding proteins involved in these pathways have been demonstrated to promote genetic instability and cancer. In fact, it has been suggested that all cancers display defects in DNA repair. It has also been demonstrated that the ability of cancer cells to repair therapeutically induced DNA damage impacts therapeutic efficacy. This has led to targeting DNA repair pathways and proteins to develop anti-cancer agents that will increase sensitivity to traditional chemotherapeutics. While initial studies languished and were plagued by a lack of specificity and a defined mechanism of action, more recent approaches to exploi...Continue Reading

References

Mar 7, 2002·Trends in Pharmacological Sciences·Alberto Chiarugi
Mar 5, 2003·The Journal of Experimental Medicine·Sean RooneyJoAnn Sekiguchi
Dec 14, 2004·Oncogene·Spencer J CollisAntony R Parker
May 12, 2005·Molecular Cancer Research : MCR·Heather J BoeckmanJohn J Turchi
Aug 23, 2005·Nucleic Acids Research·Srinivasan MadhusudanIan D Hickson
Apr 10, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Sining Chen, Giovanni Parmigiani
Apr 10, 2007·International Journal of Cancer. Journal International Du Cancer·Tomoyoshi TakenakaYoshihiko Maehara
Jun 15, 2007·The New England Journal of Medicine·Laura J NiedernhoferRichard D Wood
Sep 28, 2007·Anti-cancer Agents in Medicinal Chemistry·Tomasz Zaremba, Nicola Jane Curtin
Oct 27, 2007·Trends in Biochemical Sciences·Olivier MaillardHanspeter Naegeli
Jan 8, 2008·Nature Chemical Biology·Aude DupréJean Gautier
Feb 16, 2008·Annual Review of Biochemistry·Joseph San FilippoHannah Klein
Mar 21, 2008·Trends in Molecular Medicine·José YélamosFrançoise Dantzer
May 13, 2008·The Journal of Biological Chemistry·Stuart J HaringMarc S Wold
Apr 2, 2009·Nucleic Acids Research·Takako IshidaHitoshi Kurumizaka
Sep 3, 2009·Cancer Research·Nikhil R BhagwatLaura J Niedernhofer
Dec 10, 2009·International Journal of Radiation Biology·Penny Jeggo, Martin F Lavin
Dec 17, 2009·Histopathology·Anita MitraChristopher S Foster
Mar 3, 2010·Free Radical Biology & Medicine·Prakash PeddiAlexandros G Georgakilas
Mar 5, 2010·Nature Reviews. Cancer·Michèle RouleauGuy G Poirier
Apr 22, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Peter C FongStan B Kaye
Apr 27, 2010·DNA Repair·Sanjeevani AroraSteve M Patrick
Aug 31, 2010·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Monika GraeserNicholas C Turner

❮ Previous
Next ❯

Citations

Sep 16, 2016·Frontiers in Genetics·Elena MogilyanskyIsidore Rigoutsos
Oct 16, 2016·Expert Opinion on Biological Therapy·Surinder K Sharma, Kenneth D Bagshawe
Jan 6, 2017·Journal of Cancer Prevention·Azad KumarNilesh Kumar Sharma
Feb 7, 2017·The Journal of Veterinary Medical Science·Manabu KoikeAki Koike
May 19, 2017·Journal of the National Cancer Institute·Jac A NickoloffRobert Hromas
Feb 28, 2017·Cell & Bioscience·Anna PalovcakYanbin Zhang
Oct 11, 2017·International Journal of Molecular Sciences·Luyao WangGe Zhang
Apr 12, 2018·International Journal of Molecular Sciences·Jolene Michelle HelenaAnne Elisabeth Mercier
Jul 10, 2018·Nucleic Acids Research·Gonzalo Rodriguez-BerrigueteGeoff S Higgins
Aug 16, 2017·Endocrine-related Cancer·Sock Hoai Chan, Joanne Ngeow
Oct 31, 2018·Drug Development Research·Estefanía Burgos-MorónJosé Manuel Calderón-Montaño
Feb 5, 2019·Molecular Oncology·Nicole M ReillyAlberto Bardelli
May 28, 2019·Journal of Cellular Physiology·Jinsheng XiongPeng Liang
Feb 10, 2018·Current Medicinal Chemistry·Monika TomaTomasz Sliwinski
Dec 1, 2019·Neuro-oncology·Steven L Carroll, Jody Fromm Longo
Oct 21, 2016·MedChemComm·Bibiana I FerreiraJames B Lorens
Mar 7, 2020·Biotechnology Journal·Jinho YoonJeong-Woo Choi
Jul 9, 2020·Cancer Science·Yunlong Hu, Mingzhou Guo
May 15, 2018·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Anu PrakashEmer Bourke
May 31, 2018·Nature·Richard D Wood
Aug 24, 2018·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·B FarhoodM Najafi
Dec 14, 2018·Oncology Letters·Pina FuscoGian Paolo Tonini
Feb 27, 2019·Current Stem Cell Research & Therapy·Eloisi Caldas-LopesMonica L Guzman
Apr 25, 2019·Apoptosis : an International Journal on Programmed Cell Death·Tidarat NhukeawAdisorn Ratanaphan
Jun 26, 2020·Journal of Experimental Pharmacology·Fatemeh PourrajabAzam Sadat Hashemi
Sep 26, 2020·Biomarker Research·Aiai Gao, Mingzhou Guo
Jun 6, 2017·Frontiers in Oncology·Ana Belén Herrero, Norma Carmen Gutiérrez
Mar 1, 2019·Scientific Reports·Giovanni RandonFilippo Pietrantonio

❮ Previous
Next ❯

Related Concepts

Related Feeds

CRISPR Ribonucleases Deactivation

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on mechanisms that underlie deactivation of CRISPR ribonucleases. Here is the latest research.

CRISPR Genome Editing & Therapy

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of this system for gene editing and therapy in human diseases.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Cancer Metabolism

In order for cancer cells to maintain rapid, uncontrolled cell proliferation, they must acquire a source of energy. Cancer cells acquire metabolic energy from their surrounding environment and utilize the host cell nutrients to do so. Here is the latest research on cancer metabolism.

CRISPR (general)

Clustered regularly interspaced short palindromic repeats (CRISPR) are DNA sequences in the genome that are recognized and cleaved by CRISPR-associated proteins (Cas). CRISPR-Cas system enables the editing of genes to create or correct mutations. Discover the latest research on CRISPR here.

CRISPR for Genome Editing

Genome editing technologies enable the editing of genes to create or correct mutations. Clustered regularly interspaced short palindromic repeats (CRISPR) are DNA sequences in the genome that are recognized and cleaved by CRISPR-associated proteins (Cas). Here is the latest research on the use of CRISPR-Cas system in gene editing.

AML: Role of LSD1 by CRISPR (Keystone)

Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Acute Myeloid Leukaemia & RNA

Acute myeloid leukaemia (AML) is a common hematological type of cancer. As the population ages, there has been a rise in the frequency of AML. RNA expression has been used to see if there are different genetic profiles that exist within AML and whether these may underpin the variations in survival rates. Here is the latest research on AML and RNA.

Breast Cancer: Risk Factors

Breast cancer is a multifactorial disease that is influenced by both environmental and genetic factors. Discover the latest research on the environmental and genetic risk factors for breast cancer here.

Breast Tumorigenesis

Breast tumorigenesis involves the production or formation of tumor(s) in breast tissue. Discover the latest research on breast tumorigenesis here.

AKT Pathway

This feed focuses on the AKT serine/threonine kinase, which is an important signaling pathway involved in processes such as glucose metabolism and cell survival.

CRISPR in Cancer

CRISPR-Cas system enables the editing of genes to create or correct mutations. Given that genome instability and mutation is one of the hallmarks of cancer, the CRISPR-Cas system is being explored to genetically alter and eliminate cancer cells. Here is the latest research.

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.

Cancer Metabolism: Therapeutic Targets

Targeting the mechanisms by which cancer cells acquire energy for metabolic needs is a therapeutic target. Discover the latest research on cancer metabolism and therapeutic targets.

Cancer Genomics (Keystone)

Cancer genomics approaches employ high-throughput technologies to identify the complete catalog of somatic alterations that characterize the genome, transcriptome and epigenome of cohorts of tumor samples. Discover the latest research using such technologies in this feed.

Breast Cancer: BRCA1 & BRCA2

Mutations involving BRCA1, found on chromosome 17, and BRCA2, found on chromosome 13, increase the risk for specific cancers, such as breast cancer. Discover the last research on breast cancer BRCA1 and BRCA2 here.

Breast Cancer: Therapeutic Approaches

Several different therapeutic approaches are used to treat breast cancer. These include chemotherapy, hormonal therapy, targeted therapy, and Immunotherapy. Discover the latest research on breast cancer therapeutic approaches here.